Retrospective analysis of risk factors for fatigue in clinical trial patients (pts) with metastatic renal cell carcinoma (mRCC).
Martin Eric Gore
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Viktor Gruenwald
Consultant or Advisory Role - Astellas Pharma; Bayer; GlaxoSmithKline; Novartis; Pfizer; Roche
Honoraria - Astellas Pharma; GlaxoSmithKline; Novartis; Pfizer; Roche
Robert John Motzer
Consultant or Advisory Role - Genentech; Pfizer
Research Funding - Astellas Pharma; AVEO; Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Pfizer
David I. Quinn
Consultant or Advisory Role - Astellas Pharma; AVEO; Bayer; Dendreon; Genentech; Medivation; Novartis; Onyx; Pfizer; Prometheus
Honoraria - Astellas Pharma; AVEO; Bayer; Dendreon; Genentech; Medivation; Novartis; Onyx; Pfizer; Prometheus
Research Funding - AVEO; Bayer; Bristol-Myers Squibb; Dendreon; Genentech; Millennium; Novartis; Pfizer; Prometheus
Brian I. Rini
Consultant or Advisory Role - AVEO; Bayer/Onyx; Bristol-Myers Squibb; GlaxoSmithKline; Pfizer
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer
Xun Lin
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Julia Jane Perkins
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Ronit Simantov
Employment or Leadership Position - Pfizer
Stock Ownership - Pfizer
Toni K. Choueiri
Consultant or Advisory Role - AVEO; Bayer/Onyx; Genentech; GlaxoSmithKline; Novartis; Pfizer
Research Funding - Pfizer